Skip to content

A clinical evaluation study of transcranial direct current stimulation (tDCS) for adolescent depressive disorders

A clinical evaluation study of transcranial direct current stimulation (tDCS) for adolescent depressive disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096374
Enrollment
Unknown
Registered
2025-01-22
Start date
2024-09-10
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressive disorder

Interventions

Adolescent Depressive Disorder tDCS True Stimulation Group(1.4mA):The anode of the transcranial direct current stimulation instrument is placed on the subject's head, so that the cathode is placed on
Adolescent depressive disorder tDCS pseudostimulation group(1.4mA):The anode of the transcranial direct current stimulation apparatus was placed on the head of the subject, so that the cathode was pla
Adolescent Depressive Disorder tDCS True Stimulation Group(2.0mA):The anode of the transcranial direct current stimulation instrument is placed on the subject's head, so that the cathode is placed on
Adolescent depressive disorder tDCS pseudostimulation group(2.0mA):The anode of the transcranial direct current stimulation apparatus was placed on the head of the subject, so that the cathode was pla

Sponsors

Hefei Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Met the diagnostic criteria for depressive disorders in DSM-5; 2. Han Chinese, aged 13-18 years, right-handed; 3. Did not use antipsychotics or medications known to have cognitive effects prior to enrollment.

Exclusion criteria

Exclusion criteria: 1. Patients with neurological disorders, serious physical illnesses, psychoactive substance abuse, previous history of brain disease, mental retardation, non-cooperation in the examination (those who are unable to persist in completing the test due to severe psychiatric symptoms, or those who do not answer or respond seriously during the test), and those with obvious visual impairment. 2. Patients whose family members suffer from serious psychiatric disorders, neurological disorders, serious physical illnesses, psychoactive substance abuse, previous history of brain disease, mental retardation, non-cooperation in the examination, and those with obvious visual impairment. 3. Patients who have contraindications to MRI examination.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale Score;

Secondary

MeasureTime frame
Hamilton Anxiety Scale Score;Overall Clinical Efficacy Scale Score;

Countries

China

Contacts

Public ContactHui Zhong

Hefei Fourth People's Hospital

zhui1324@163.com+86 135 1560 5358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026